Translational Psychiatry (Feb 2020)

Contribution of common and rare variants to bipolar disorder susceptibility in extended pedigrees from population isolates

  • Jae Hoon Sul,
  • Susan K. Service,
  • Alden Y. Huang,
  • Vasily Ramensky,
  • Sun-Goo Hwang,
  • Terri M. Teshiba,
  • YoungJun Park,
  • Anil P. S. Ori,
  • Zhongyang Zhang,
  • Niamh Mullins,
  • Loes M. Olde Loohuis,
  • Scott C. Fears,
  • Carmen Araya,
  • Xinia Araya,
  • Mitzi Spesny,
  • Julio Bejarano,
  • Margarita Ramirez,
  • Gabriel Castrillón,
  • Juliana Gomez-Makhinson,
  • Maria C. Lopez,
  • Gabriel Montoya,
  • Claudia P. Montoya,
  • Ileana Aldana,
  • Javier I. Escobar,
  • Jorge Ospina-Duque,
  • Barbara Kremeyer,
  • Gabriel Bedoya,
  • Andres Ruiz-Linares,
  • Rita M. Cantor,
  • Julio Molina,
  • Giovanni Coppola,
  • Roel A. Ophoff,
  • Gabriel Macaya,
  • Carlos Lopez-Jaramillo,
  • Victor Reus,
  • Carrie E. Bearden,
  • Chiara Sabatti,
  • Nelson B. Freimer

DOI
https://doi.org/10.1038/s41398-020-0758-1
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Current evidence from case/control studies indicates that genetic risk for psychiatric disorders derives primarily from numerous common variants, each with a small phenotypic impact. The literature describing apparent segregation of bipolar disorder (BP) in numerous multigenerational pedigrees suggests that, in such families, large-effect inherited variants might play a greater role. To identify roles of rare and common variants on BP, we conducted genetic analyses in 26 Colombia and Costa Rica pedigrees ascertained for bipolar disorder 1 (BP1), the most severe and heritable form of BP. In these pedigrees, we performed microarray SNP genotyping of 838 individuals and high-coverage whole-genome sequencing of 449 individuals. We compared polygenic risk scores (PRS), estimated using the latest BP1 genome-wide association study (GWAS) summary statistics, between BP1 individuals and related controls. We also evaluated whether BP1 individuals had a higher burden of rare deleterious single-nucleotide variants (SNVs) and rare copy number variants (CNVs) in a set of genes related to BP1. We found that compared with unaffected relatives, BP1 individuals had higher PRS estimated from BP1 GWAS statistics (P = 0.001 ~ 0.007) and displayed modest increase in burdens of rare deleterious SNVs (P = 0.047) and rare CNVs (P = 0.002 ~ 0.033) in genes related to BP1. We did not observe rare variants segregating in the pedigrees. These results suggest that small-to-moderate effect rare and common variants are more likely to contribute to BP1 risk in these extended pedigrees than a few large-effect rare variants.